Literature DB >> 1826701

Immunodominance is altered in T cell receptor (beta-chain) transgenic mice without the generation of a hole in the repertoire.

D L Perkins1, Y S Wang, D Fruman, J G Seidman, I J Rimm.   

Abstract

Despite the tremendous plasticity of the TCR repertoire, T cells recognize a limited number of antigenic sites (frequently a single site, or immunodominant epitope) on a complex protein Ag. Current models suggest that the immunodominant epitope of a complex protein is the processed peptide that binds to the MHC molecule with the highest affinity. Conversely, the inability of the T cell population to recognize a specific epitope, termed a "hole" in the repertoire, can prevent the immunodominance of a peptide despite efficient processing and MHC binding of the peptide. The role of specific TCR alpha- or beta-chains in determining MHC restriction and recognizing specific epitopes is complex and incompletely understood. To evaluate the contribution of each TCR chain to the functional diversity of the T cell repertoire, we investigated in vivo the T cell response to phage lambda-repressor protein in transgenic mice expressing a single rearranged beta-chain gene (C57L beta mice) in association with the complete germline alpha-chain repertoire. Our results demonstrate that expression of the TCR beta-chain transgene alters the immunodominant epitope recognized by T cells. However, after immunization with the appropriate peptide the transgenic mice can also respond to the nonimmunodominant epitope; thus, the expression of the TCR beta-chain transgene does not create a hole in the repertoire. These data indicate that the primary site, or immunodominant epitope, of an Ag recognized by T cells can be altered by the preimmune TCR repertoire independent of antigen processing and MHC affinity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826701

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Determinants of immunodominance for CD4 T cells.

Authors:  AeRyon Kim; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2015-01-08       Impact factor: 7.486

2.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

3.  Differentiation of V beta 8.2+ CD4+ T cells induced by a superantigen: roles of antigen-presenting cells and cytokines.

Authors:  A J McKnight; C M Shea; G R Wiens; I J Rimm; A K Abbas
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

4.  Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire.

Authors:  K Daly; P Nguyen; D L Woodland; M A Blackman
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing.

Authors:  AeRyon Kim; Tatiana N Boronina; Robert N Cole; Erika Darrah; Scheherazade Sadegh-Nasseri
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

6.  Immunodomination during peripheral vaccinia virus infection.

Authors:  Leon C W Lin; Inge E A Flesch; David C Tscharke
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

7.  T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.

Authors:  V K Kuchroo; M Collins; A al-Sabbagh; R A Sobel; M J Whitters; S S Zamvil; M E Dorf; D A Hafler; J G Seidman; H L Weiner
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

Review 8.  Estimating the diversity, completeness, and cross-reactivity of the T cell repertoire.

Authors:  Veronika I Zarnitsyna; Brian D Evavold; Louis N Schoettle; Joseph N Blattman; Rustom Antia
Journal:  Front Immunol       Date:  2013-12-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.